CTRI/2017/04/008401已完成未知
INTRAVENOUS VERSUS INTRA-ARTICULAR ADMINISTRATION OF TRANEXAMIC ACID FOR CONTROL OF PERI-OPERATIVE BLOOD LOSS IN TOTAL KNEE REPLACEMENT SURGERIES - A RANDOMISED CONTROLLED EQUIVALANCE TRIAL.
Sri Sathya Sai Institute of Higher Medical Sciences Prasanthigram0 个研究点目标入组 138 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 138
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. All patients undergoing total knee arthroplasty for primary arthroplasty knee
- •2.Patients who are willing to participate in the study.
- •3.Patient without exclusion criteria.
排除标准
- •1.Allergy to the TXA
- •2.H/O Coagulopathy,abnormal PT or APTT
- •3.Past H/O Thromboembolic event
- •4.Treatment with Aspirin or NSAIDS in the last week
- •5.plasma creatinine > 115 micro moles /litre for males
- •And >100 micro moles/litre in females.
- •6.Acute infection[eg;leukocytosis or fever]
- •7.Malignancy
- •8.MI in preceding 12 months,unstable angina
- •9.Patient who were given plasma in perioperative period.
研究者
相似试验
招募中
不适用
Role of tranexamic acid in reducing blood loss in hip fracture surgeriesCTRI/2019/10/021667Sri Sathya Sai Institute of Higher Medical Sciences Prasanthigram
招募中
2 期
effects of rituximab in patients with pemphigus vulgaris with oral lesionsIRCT20240604062002N1Tabriz University of Medical Sciences20
进行中（未招募）
1 期
A clinical trial to test the efficacy and safety of a bone marrow cell preparation to treat Critical Limb Ischemia in Subjects with Diabetes Mellitus.EUCTR2016-000240-34-ATRexgenero Limited60
进行中（未招募）
1 期
A clinical trial to test the efficacy and safety of a bone marrow cell preparation to treat Critical Limb Ischemia in Subjects with Diabetes Mellitus.Critical Limb Ischemia in patients with Diabetes MellitusMedDRA version: 19.1Level: LLTClassification code 10077142Term: Limb ischemiaSystem Organ Class: 100000004866MedDRA version: 19.1Level: LLTClassification code 10058069Term: Critical limb ischemiaSystem Organ Class: 100000004866MedDRA version: 19.1Level: PTClassification code 10012601Term: Diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2016-000240-34-NLRexgenero Limited60
进行中（未招募）
1 期
A clinical trial to test the efficacy and safety of intra-arterial administration of REX-001 to treat ischaemic ulcers in subjects with Critical Limb Ischaemia Rutherford Category 5 and Diabetes Mellitus.Critical Limb Ischemia in patients with Diabetes MellitusMedDRA version: 21.1Level: LLTClassification code 10077142Term: Limb ischemiaSystem Organ Class: 100000004866MedDRA version: 24.0Level: LLTClassification code 10058069Term: Critical limb ischemiaSystem Organ Class: 100000004866MedDRA version: 20.0Level: PTClassification code 10012601Term: Diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2016-003980-21-PTRexgenero Limited78